S2CID 23096987
Palmer SC, Tendal B, Mustafa RA et al (2021) Sodiumglucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
2 Use in Preclinical Research In preclinical research, scientists investigate GLP-1R agonists using animal models, most commonly rodent models such as mice and rats, and sometimes nonhuman primate models
Better blood flow means faster removal of waste products and a more efficient delivery of the body's natural repair crews
Enhances metabolic and physical function: NMN supplementation has been shown to increase physical performance, energy, and metabolic health through its effect on NAD+ levels
But the studys authors, led by Stanley Hazen, MD, PhD, of the Cleveland Clinic, never stated any such thing